Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|September 1, 1996
R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergyV A Boussiotis, N A Pardo, H Collins, et al.
The Journal of Clinical Investigation|August 1, 1994
Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantationK Sugita, Y Nojima, K Tachibana, et al.
Blood|February 15, 1995
Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantationJ Kameoka, T Sato, Y Torimoto, et al.
Blood|January 15, 1992
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantationR J Soiffer, C Murray, K Cochran, et al.
Bone Marrow Transplantation|March 29, 2002
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantationJ H Antin, S J Lee, D Neuberg, et al.
Bone Marrow Transplantation|December 1, 1990
Autoimmune pancytopenia following allogeneic bone marrow transplantationT R Klumpp, M A Caligiuri, S N Rabinowe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanomaR J Soiffer, P B Chapman, C Murray, et al.
Bone Marrow Transplantation|July 5, 2006
Quality of life associated with acute and chronic graft-versus-host diseaseS J Lee, H T Kim, V T Ho, et al.
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
Oral Diseases|December 3, 2017
Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot studyAcf Motta, Q Zhan, A Larson, et al.
Pageof 8